Cancer therapy by targeting hypoxia-inducible factor-1 - PubMed (original) (raw)
Review
Cancer therapy by targeting hypoxia-inducible factor-1
Y Li et al. Curr Cancer Drug Targets. 2010 Nov.
Abstract
Tumors are invariably less well-oxygenated than the normal tissues from which they arose. Hypoxia-inducible factor-1 (HIF-1), a key transcriptional regulator, plays a central role in the adaptation of tumor cells to hypoxia by activating the transcription of genes, which regulate several biological processes including angiogenesis, cell proliferation, survival, glucose metabolism and migration. The expression, activity and stability of HIF-1 is not only induced in response to reduced oxygen availability but also modulated through PI-3K, MAPK, autocrine signaling pathways, E3 ubiquitin ligases, and other regulators. The regulators and effects of HIF-1 in cancer have intensively provided us a new clue for the HIF-1 targeting anticancer therapy. This review evaluates the HIF-1 structure, the regulation mechanisms, the functions in cancer and corresponding anticancer strategies.
Similar articles
- Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
Burroughs SK, Kaluz S, Wang D, Wang K, Van Meir EG, Wang B. Burroughs SK, et al. Future Med Chem. 2013 Apr;5(5):553-72. doi: 10.4155/fmc.13.17. Future Med Chem. 2013. PMID: 23573973 Free PMC article. Review. - Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer.
Agani F, Jiang BH. Agani F, et al. Curr Cancer Drug Targets. 2013 Mar;13(3):245-51. doi: 10.2174/1568009611313030003. Curr Cancer Drug Targets. 2013. PMID: 23297826 Review. - [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
Niu F, Li Y, Lai FF, Chen XG. Niu F, et al. Yao Xue Xue Bao. 2014 Jun;49(6):832-6. Yao Xue Xue Bao. 2014. PMID: 25212028 Review. Chinese. - Recent agents targeting HIF-1α for cancer therapy.
Hu Y, Liu J, Huang H. Hu Y, et al. J Cell Biochem. 2013 Mar;114(3):498-509. doi: 10.1002/jcb.24390. J Cell Biochem. 2013. PMID: 22961911 Review. - Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G, Giuliani A. Martínez-Sánchez G, et al. J Exp Clin Cancer Res. 2007 Mar;26(1):39-50. J Exp Clin Cancer Res. 2007. PMID: 17550131 Review.
Cited by
- Emerging role of circRNAs in cancer under hypoxia.
Lai Q, Li W, Wang H, Xu S, Deng Z. Lai Q, et al. Oncol Lett. 2022 Sep 5;24(4):372. doi: 10.3892/ol.2022.13492. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36238836 Free PMC article. Review. - Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.
Vadlapatla RK, Vadlapudi AD, Mitra AK. Vadlapatla RK, et al. Curr Drug Targets. 2013 Jul;14(8):919-35. doi: 10.2174/13894501113149990015. Curr Drug Targets. 2013. PMID: 23701276 Free PMC article. Review. - Roles of circRNAs in the tumour microenvironment.
Zhang Q, Wang W, Zhou Q, Chen C, Yuan W, Liu J, Li X, Sun Z. Zhang Q, et al. Mol Cancer. 2020 Jan 23;19(1):14. doi: 10.1186/s12943-019-1125-9. Mol Cancer. 2020. PMID: 31973726 Free PMC article. Review. - Matrine Reverses the Warburg Effect and Suppresses Colon Cancer Cell Growth via Negatively Regulating HIF-1α.
Hong X, Zhong L, Xie Y, Zheng K, Pang J, Li Y, Yang Y, Xu X, Mi P, Cao H, Zhang W, Hu T, Song G, Wang D, Zhan YY. Hong X, et al. Front Pharmacol. 2019 Nov 28;10:1437. doi: 10.3389/fphar.2019.01437. eCollection 2019. Front Pharmacol. 2019. PMID: 31849679 Free PMC article. - Role of Notch and its oncogenic signaling crosstalk in breast cancer.
Guo S, Liu M, Gonzalez-Perez RR. Guo S, et al. Biochim Biophys Acta. 2011 Apr;1815(2):197-213. doi: 10.1016/j.bbcan.2010.12.002. Epub 2010 Dec 28. Biochim Biophys Acta. 2011. PMID: 21193018 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous